CompletedNCT01022489
High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Randomized Controlled Study
Device studyAges 16–65France
Understand this study
Who was this study for?
Listed age limits: 16 years to 65 years.
- Listed locations
- Caen, FranceSee all locations and recruitment
- Activities
- Device procedures described in the protocol · Placebo comparator
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateAugust 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 72
- Sponsor
- University Hospital, Caen
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- France
- Age range
- From 16 Years to 65 Years
- Official registry ID
- NCT01022489
- Official title
Show the full official title
Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) at High Frequency With Neuronavigation in the Treatment of Auditory Hallucinations : A Randomized Multicentric Controlled Study
Recruitment & locations
CompletedCaen
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Caen, a hospital or academic medical center.
Who was this study for?
Listed age limits: 16 years to 65 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me